| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 29,161 | 26,923 | 25,853 | 25,358 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit | 29,161 | 26,923 | 25,853 | 25,358 | | | Operating Expenses | | Research Development | 37,237 | 40,778 | 40,447 | 41,399 | | Selling General and Administrative | 10,657 | 8,689 | 7,417 | 10,451 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (18,733) | (22,544) | (22,011) | (26,492) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 327 | 422 | 240 | 1,223 | | Earnings Before Interest And Taxes | (18,406) | (22,122) | (21,771) | (25,269) | | Interest Expense |
-
| 1 |
-
| 252 | | Income Before Tax | (18,406) | (22,123) | (21,771) | (25,521) | | Income Tax Expense | (24) | (31) | (31) | 282 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (18,382) | (22,092) | (21,740) | (25,803) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (18,382) | (22,092) | (21,740) | (25,803) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($18,382) | ($22,092) | ($21,740) | ($25,803) |
|
0.10% Nasdaq 0.00%
Income Statement
